Cochrane Abstracts
Intravesical gemcitabine for non‐muscle invasive bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Gemcitabine for Non‐muscle Invasive Bladder Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437239/all/Intravesical_gemcitabine_for_non‐muscle_invasive_bladder_cancer.
Intravesical gemcitabine for non‐muscle invasive bladder cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/all/Intravesical_gemcitabine_for_non‐muscle_invasive_bladder_cancer. Accessed March 20, 2025.
Intravesical gemcitabine for non‐muscle invasive bladder cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/all/Intravesical_gemcitabine_for_non‐muscle_invasive_bladder_cancer
Intravesical Gemcitabine for Non‐muscle Invasive Bladder Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/all/Intravesical_gemcitabine_for_non‐muscle_invasive_bladder_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical gemcitabine for non‐muscle invasive bladder cancer
ID - 437239
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437239/all/Intravesical_gemcitabine_for_non‐muscle_invasive_bladder_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
